Endoscopy & Procedures · Article 175

How Should Post-ERCP Pancreatitis Be Prevented?

Post-ERCP pancreatitis prevention requires a structured, evidence-based clinical approach. This review summarizes the key diagnostic, management, monitoring and decision points for gastroenterology and hepatology practice.

Post-ERCP pancreatitis prevention clinical reference — Related free clinical resource: Endoscopy and Diagnostic Imaging.

Post-ERCP pancreatitis prevention: practical clinical approach

This page focuses on Post-ERCP pancreatitis prevention with emphasis on decisions that change patient care, common pitfalls, and the current evidence base.

External guidance for Post-ERCP pancreatitis prevention

Clinical takeaway: For Post-ERCP pancreatitis prevention, decisions should integrate current guidelines, patient-specific risk, and the evidence summarized below.

Answer first: Post-ERCP pancreatitis (PEP) prevention should be built into every ERCP. Current ASGE guidance recommends periprocedural rectal NSAIDs for both unselected and high-risk patients unless contraindicated, wire-guided cannulation rather than contrast-guided cannulation, and prophylactic pancreatic stents in selected high-risk patients. Adequate lactated-Ringer’s hydration is also used when not contraindicated. Most importantly, avoid unnecessary ERCP by using MRCP or EUS for diagnosis when therapeutic intervention is not required.

The best PEP prevention is avoiding unnecessary ERCP

ERCP should primarily be a therapeutic procedure.

NSAIDs are the universal pharmacologic foundation

Rectal indomethacin or diclofenac reduces PEP in average- and high-risk patients.

Technique matters

Wire-guided cannulation and minimizing pancreatic instrumentation reduce injury.

Practical clinical algorithm

1. Confirm a therapeutic indication for ERCP.

2. Give rectal NSAID unless contraindicated.

3. Use wire-guided cannulation and minimize attempts.

4. Place a prophylactic pancreatic stent in appropriate high-risk situations.

5. Use appropriate hydration when safe.

6. Monitor high-risk patients after the procedure.

Common mistakes to avoid

Performing diagnostic ERCP when MRCP/EUS would suffice.
Forgetting rectal NSAID in average-risk patients.
Repeated traumatic cannulation attempts.
Failing to stent a high-risk pancreatic duct after repeated instrumentation.
Aggressive hydration in heart or renal failure without adjustment.

Trainee takeaway

PEP prevention is multimodal: appropriate indication, rectal NSAID, careful cannulation, selective pancreatic stenting and sensible hydration.

Frequently asked questions

Should rectal NSAIDs be given to average-risk patients?

Yes, ASGE recommends them unless contraindicated.

Who needs a pancreatic stent?

Selected high-risk patients, especially after significant pancreatic duct instrumentation.

Does hydration help?

Yes, but it must be individualized to cardiovascular and renal status.

References

1. Thomson ABR. Endoscopy and Diagnostic Imaging. Part II. CAPstone Academic Publishers; 2012.

2. Thomson ABR. Clinical Pharmacology, Physiology and Pathophysiology: Gastroenterology, Hepatology, and Pancreaticobiliary Disorders. CAPstone Academic Publishers; 2024.

3. ASGE Standards of Practice Committee. ASGE guideline on post-ERCP pancreatitis prevention strategies. Gastrointest Endosc. 2023.

Educational content only. Clinical decisions should incorporate the individual patient, local resources, product labeling, and the most current applicable guideline or regulatory information.

← Back to Clinical Questions